(Discontinued) 040-000-256 Metformin (Hydrochloride), CAS 1115-70-4

About This Item

Catalog No.
040-000-256

Discontinued

Synonyms 3-(diaminomethylidene)-1,1-dimethylguanidine, Glucophage
Keywords Type 2 diabetes, blood glucose, PCOS, overweight, obesity
Related products Thiazolidinediones, Berberine, Berberine Hydrochloride, Silybum Marianum Extract

Quantity

kg

Technical Service

Need help? Our team of experienced scientists is here for you.

Description

Metformin Hydrochloride Specifications


Product Name Metformin (Hydrochloride)
CAS Registry Number 1115-70-4
Molecular Formula ‎C4H11N5 • HCl
Molecular Weight 165.6
Purity >99%
Appearance White powder
Boiling point 229.23°C
Density 1.0743
Shelf life 2 years
Functions Reduce blood glucose, anti-cancer, treatment of type 2 diabetes and other metabolism diseases

Metformin Hydrochloride Description


Metformin is now a first-line agent for the treatment of type 2 diabetes, and can be used alone or in combination with sulfonylureas, thiazolidinediones or other hypoglycemic agents. It can increase the activity of AMPK and reduces blood glucose by more than 50% in mice, according to the research. In recent years, more and more research has focused on the role of metformin in cancer.

Metformin Hydrochloride Benefits


  • Blood Sugar Control: Metformin works by reducing the amount of glucose (sugar) produced by the liver and improving the body's response to insulin, a hormone that regulates the absorption of sugar into your cells. This helps to lower blood sugar levels and improve blood sugar control.
  • Weight Management: Metformin can help with weight loss in some people with type 2 diabetes. It may reduce appetite and help people feel full longer, which can lead to a decrease in calorie intake.
  • Cardiovascular Benefits: Metformin has been shown to have cardiovascular benefits. It may reduce the risk of heart disease and stroke in people with type 2 diabetes.

Metformin Hydrochloride Uses


  • Type 2 Diabetes: Metformin is used together with diet and exercise to improve blood sugar control in adults and children with type 2 diabetes mellitus.
  • Prediabetes: In some cases, metformin is used to treat people with prediabetes to prevent the progression to type 2 diabetes.
  • Polycystic Ovary Syndrome (PCOS): Metformin is sometimes used to treat insulin resistance in women with PCOS, a hormonal disorder that can cause irregular periods, unwanted hair growth, and infertility.

Metformin Hydrochloride Side Effects


  • Gastrointestinal Symptoms: These may include nausea, vomiting, stomach upset, diarrhea, and loss of appetite. These side effects often occur when starting the medication and may diminish over time.
  • Vitamin B12 Deficiency: Long-term use of metformin can lead to vitamin B12 deficiency, which can cause anemia and nerve damage.
  • Lactic Acidosis: Although rare, metformin can cause a serious, life-threatening condition called lactic acidosis, particularly in people with kidney problems, liver disease, or serious infections. Symptoms include severe drowsiness, dizziness, slow or irregular heartbeat, flushed face, shortness of breath, and stomach pain.

Reference:
  1. Kim, E.K., Lee, S.H., Jhun, J.Y., et al. Metformin prevents fatty liver and improves the balance of white/brown adipose in an obesity mouse model by inducing FGF21. Mediators Inflamm. 5813030, (2016).
  2. Lautatzis, ME; Goulis, DG; Vrontakis, M. Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review. Metabolism: clinical and experimental. November 2013, 62 (11): 1522–34.
  3. Dunn CJ, Peters DH. Metformin. A review of its pharmacological properties and therapeutic use in non-insulin-dependent diabetes mellitus. Drugs. May 1995, 49 (5): 721–49.

Reviews

5 Stars
2
4 Stars
0
3 Stars
0
2 Stars
0
1 Stars
0
Write a review

Get a Quote

Send us an inquiry now to find out more information and the latest prices, thanks!
Product Name
Quantity
Name
Email
Phone
Company
Application
Country
United States
  • United States
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antarctica
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos (Keeling) Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Croatia
  • Cuba
  • Cyprus
  • Czech Republic
  • Democratic Republic of Congo
  • Denmark
  • Disputed Territory
  • Djibouti
  • Dominica
  • Dominican Republic
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Federated States of Micronesia
  • Fiji
  • Finland
  • France
  • French Guyana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Iraq-Saudi Arabia Neutral Zone
  • Ireland
  • Israel
  • Italy
  • Ivory Coast
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Libya
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands Antilles
  • Netherlands
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • North Korea
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestinian Territories
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Helena and Dependencies
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • Samoa
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and South Sandwich Islands
  • South Korea
  • Spain
  • Spratly Islands
  • Sri Lanka
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syria
  • Taiwan
  • Tajikistan
  • Tanzania
  • Thailand
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks And Caicos Islands
  • Tuvalu
  • US Virgin Islands
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Vatican City
  • Venezuela
  • Vietnam
  • Wallis and Futuna
  • Western Sahara
  • Yemen
  • Zambia
  • Zimbabwe
Comments
I would like to join the mailing list to receive updates from Stanford Chemicals.
Check Code